Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
01/2013
01/08/2013US8349834 Dioxolane derivates for the treatment of cancer
01/08/2013CA2653941C Substituted amino purine derivatives and uses thereof
01/03/2013WO2013000280A1 9-sulfonyl-9h-purine derivative, preparation method and use thereof
01/03/2013US20130005749 Novel formulation and treatment methods
01/03/2013US20130005687 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
01/03/2013US20130005677 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections
01/02/2013EP2540725A1 Polymorphs of 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin
01/02/2013EP2540724A1 Hydrochlorides and hydrates of 1-[(3-cyano-pyridin-2-yl) methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-amino-piperidin-1-yl)-xanthi, their manufacture and use of same as medicine
01/02/2013CN102850355A 9-sulfonyl-9H-purine derivatives, and preparation method and use thereof
01/02/2013CN102850354A Preparation method of high-purity carbamazepine (CBZ)-valaciclovir
01/02/2013CN102850353A Preparation method of carbamazepine (CBZ)-valaciclovir
01/01/2013US8344125 Modified iRNA agents
01/01/2013US8343961 Substituted heterocyclic compounds
12/2012
12/27/2012US20120330009 Triazole compounds that modulate hsp90 activity
12/27/2012US20120329809 Purine compounds used as cb2 agonists
12/27/2012US20120329776 Heterocyclic compounds and uses thereof
12/27/2012US20120329747 Novel hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells
12/26/2012EP2537830A1 Compounds and compositions as protein kinase inhibitors
12/26/2012EP2536724A1 Process for preparing entecavir and its intermediates
12/26/2012CN102838601A Selective phosphatidylinositol-3 kinase delta inhibitor
12/26/2012CN102838600A Phenylquinazoline PI3Kdelta inhibitors
12/26/2012CN102838599A Polymorphs
12/25/2012US8338593 Agonists; Treatment of Hepatitis C virus; phosphinate-substituted purine derivatives
12/20/2012WO2012172043A1 Purine derivatives and their use as pharmaceuticals for prevention or treatment of bacterial infections
12/20/2012US20120322815 Pharmaceutical composition containing a3 adenosine receptor agonist
12/20/2012US20120322799 Deuterated compounds useful for treating neurodegenerative diseases
12/19/2012EP2534150A2 Methods of treating viral infection
12/19/2012EP2534149A1 6-amino-2-{ [ (1s)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
12/19/2012EP2534148A1 Purine derivatives and their pharmaceutical uses
12/19/2012CN102827165A Method for directionally preparing theophylline-saccharin eutectic through membrane technology
12/19/2012CN102260262B Method for purifying entecavir and tablets
12/18/2012CA2653247C Methods for selective n-9 glycosylation of purines
12/13/2012WO2012151525A9 Novel compounds as modulators of protein kinases
12/13/2012US20120316185 Cyclohexyl Amide Derivatives as CRF Receptor Antagonists
12/13/2012US20120316124 Isoxazoline derivatives as insecticides
12/13/2012US20120315291 Purine derivatives and their pharmaceutical uses
12/12/2012EP2531490A1 Cyclohexyl amide derivatives as crf receptor antagonists
12/12/2012EP2531196A2 Pterostilbene cocrystals
12/12/2012CN101899063B Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one
12/12/2012CN101701027B Catalytic cracking method of nucleoside compound
12/11/2012US8329926 Antiviral compounds
12/11/2012US8329899 Pyrazole compounds that modulate HSP90 activity
12/06/2012WO2012167053A1 Novel immune system modulators
12/06/2012WO2012166706A2 Supramolecular nanofibers and hydrogels based on oligopeptides functionalized with nucleobases
12/06/2012WO2012163373A1 Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir
12/06/2012WO2012138894A4 Hsp90 inhibitors
12/06/2012US20120309705 Novel 3'-deoxy-3'-methylidene-beta-l-nucleosides
12/06/2012US20120308652 Oral form of administration comprising entecavir
12/06/2012US20120308609 6-amino-2--9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
12/06/2012CA2837207A1 Novel immune system modulators
12/05/2012CN102807568A Thiadiazole derivative DPP-IV (dipeptidyl peptidase IV) inhibitor
12/04/2012US8324381 Preparation of ester of purine derivatives
12/04/2012US8324224 A2B adenosine receptor antagonists
12/04/2012CA2548323C Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions
11/2012
11/29/2012WO2012160030A1 Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/29/2012US20120302748 Treatment or prophylaxis of proliferative conditions
11/29/2012CA2833203A1 Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/28/2012EP2527344A1 Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/28/2012EP2526949A1 Agents for treating migraine
11/28/2012EP2526101A1 Crystalline forms of a purine derivative
11/28/2012CN102803263A Purine compounds used as cb2 agonists
11/28/2012CN102803228A Acid-labile trigger units
11/28/2012CN102796102A Caffeine hapten, conjugate, applications of caffeine hapten and conjugate, and method for detecting or determining caffeine
11/28/2012CN102367254B More stable doxofylline compound and pharmaceutical composite thereof
11/28/2012CN102127081B Preparation method of adenine
11/28/2012CN101851239B Ganciclovir recovery method
11/28/2012CN101805380B Method for preparing (3S, 5S)-2, 3-dihydroxyl-5-hydroxymethyl tetrahydrofuran triacetate
11/27/2012US8318750 Organic compounds
11/27/2012US8318718 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
11/27/2012US8318701 Phosphonate analogs of HIV inhibitor compounds
11/27/2012US8318700 Lung-targeted drugs
11/27/2012US8318201 Method of stabilizing diarylvinylene compound
11/27/2012CA2487805C Peptide deformylase inhibitors
11/22/2012US20120296091 Polymorphs
11/22/2012US20120295915 Azabenzimidazoles as fatty acid synthase inhibitors
11/22/2012US20120295283 Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteins
11/22/2012US20120294901 Novel cochleate formulations
11/21/2012CN1980930B 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and the use in the form of a DPP-IV inhibitor
11/21/2012CN102786524A Refining method of entecavir for treating hepatitis B
11/21/2012CN101918000B Use of purine derivatives for the manufacture of a medicament
11/15/2012WO2012152837A1 Polymorph of linagliptin benzoate
11/15/2012US20120289496 Novel compounds as modulators of protein kinases
11/15/2012CA2835332A1 Polymorph of linagliptin benzoate
11/14/2012CN102775406A Method for preparing 6-aminopurine
11/14/2012CN102775405A High-solubility doxofylline compound
11/13/2012US8309718 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
11/13/2012US8309555 Compositions and methods for inducing cell dedifferentiation
11/13/2012CA2539467C Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide
11/08/2012WO2012151525A1 Novel compounds as modulators of protein kinases
11/08/2012WO2012150715A1 Novel 11c labeling compound, method for producing same, and use of same
11/08/2012US20120283438 Compounds
11/08/2012CA2833935A1 Novel compounds as modulators of protein kinases
11/07/2012EP2520574A1 Amiloride analogues substituted on the cyclic guanidine moiety as ENaC blockers for treating respiratory diseases
11/07/2012EP2519519A2 Substituted naphthalenyl-pyrimidine compounds
11/07/2012CN102766103A 2-sulfo-4-amino-1-naphthol derivative and preparation method and application thereof
11/06/2012US8304419 Chemical compounds
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/01/2012WO2012148550A1 Prodrugs of therapeutic compounds
11/01/2012WO2012146667A1 Imidazopyridine derivatives as pi3k inhibitors
11/01/2012WO2012146666A1 Pyrrolotriazinone derivatives as pi3k inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 120